WithdrawnPhase 2NCT02190799

Anti-MERS-CoV Convalescent Plasma Therapy

Studying Infant acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
King Abdullah International Medical Research Center
Principal Investigator
Yaseen M Arabi, MD
King Abdullah International Medical Research Center
Intervention
Convalescent plasma(biological)
Eligibility
14 years · All sexes
Timeline
20142016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02190799 on ClinicalTrials.gov

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Infant acute respiratory distress syndrome

← Back to all trials